GE Healthcare Collaborates with RaySearch to Improve Radiation Oncology Treatment Planning

Chicago/Stockholm – May 9, 2022: GE Healthcare is proud to announce that it has entered into an agreement to collaborate with RaySearch Laboratories AB (publ), a leading radiation oncology software provider, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to simplify how radiation will be targeted to shrink a tumor.... Read more

GE Healthcare and Hampshire Hospitals enter long-term radiology partnership to transform patient care in the region

The 10-year agreement between the Hampshire Hospitals NHS Foundation Trust and GE Healthcare will cover 120 pieces of radiology equipment and will make use of AI to enhance cancer diagnosis Hampshire, UK – April 25, 2022 – GE Healthcare and the Hampshire Hospitals NHS Foundation Trust (HHFT) have signed a 10-year partnership agreement with the... Read more

PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System

Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 7, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated... Read more

GE Healthcare and Leading Korean Hospital Aim to Accelerate AI Ecosystem Using GE’s New Edison Digital Health Platform

Seoul National University Bundang Hospital to leverage GE Healthcare’s artificial intelligence (AI) capabilities to take the lead in using medical AI in their hospital system. The two collaborators intend to support and accelerate Korean start-ups to test and develop clinical applications on Edison Digital Health Platform Seoul, South Korea – March 31, 2022 — GE... Read more

GE Healthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical

First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care Builds on market leadership with SPECT agent DaTscan™ (Ioflupane I 123 Injection), to... Read more

GE Healthcare, AliveCor Partnership Aims to Increase Convenience for Patients and Help Reduce Cardiac-Related Hospitalizations by Improving the Quality and Integration of Patient Data

Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device, strengthening the care continuum from hospital into the home, or anytime, anywhere. Used by 87 percent of... Read more

KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neurodevelopmental Disorders

SINGAPORE and MENLO PARK, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — KK Women’s and Children’s Hospital (KKH) and PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration to leverage PacBio technology in understanding the genetic causes of neurodevelopmental disorders. As part of the Bringing Research Innovations for the... Read more